High Risk for Thoracotomy but not Thoracoscopic Lobectomy

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Pulmonary Medicine

Background:

• Pulmonary lobectomy is standard for non-small cell lung cancer (NSCLC).
• High-risk patients with compromised lung function may be excluded from surgery.
• Identifying high-risk individuals accurately is crucial for treatment decisions.

Purpose of the Study:

• To review institutional outcomes of open thoracotomy versus VATS lobectomy in high-risk patients.
• To compare complication rates and survival between high-risk and standard-risk groups.
• To evaluate the safety and efficacy of VATS in high-risk NSCLC patients.

Main Methods:

• Retrospective review of lobectomy cases from 2002-2010.
• Patients classified as high-risk (HR) or standard-risk (SR) using established criteria.
• Comparison of outcomes between open and VATS approaches within risk groups.

Main Results:

• High-risk patients (72) had higher overall and pulmonary complication rates than standard-risk patients (536).
• VATS lobectomy in high-risk patients showed no significant difference in complications compared to standard-risk VATS.
• High-risk patients undergoing open lobectomy had significantly lower survival than those treated with VATS or standard-risk open surgery.

Conclusions:

• VATS lobectomy is a feasible and safe procedure for high-risk NSCLC patients.
• VATS offers decreased morbidity and comparable survival to standard-risk patients.
• VATS lobectomy should be considered for patients previously deemed inoperable due to high risk.